This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: W Marston Linehan: Innovator in Hypercalcemia Treatment
Introduction
W Marston Linehan is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of hypercalcemia. His innovative approach has led to the development of a method that utilizes suramin and its active analogues to effectively lower calcium plasma levels in patients.
Latest Patents
Linehan holds a patent for "Suramin and active analogues thereof in the treatment of hypercalcemia." This patent discloses a method for treating hypercalcemia by administering an effective amount of suramin or its active analogues. Human data indicates that a single course of treatment can lower plasma calcium levels to normal for up to three months. This breakthrough has the potential to significantly improve patient outcomes.
Career Highlights
Linehan is associated with the United States of America as represented by the Department of Health. His work has been instrumental in advancing medical treatments and improving the quality of life for patients suffering from hypercalcemia. His dedication to research and innovation has established him as a respected figure in the medical community.
Collaborations
Linehan has collaborated with notable colleagues, including McClellan M Walther and Renato V LaRocca. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
W Marston Linehan's contributions to the treatment of hypercalcemia through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the medical field and offers hope for those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
